Caption Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Caption Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,000	Closed	-$593K	–	1651
2026 Q1	$593K	Hold	40,000	–	–	﹤0.01%	1166
2025 Q4	$638K	Sell	40,000 -2,500	-6%	-$35.4K	﹤0.01%	1193
2025 Q3	$470K	Sell	42,500 -2,500	-6%	-$27.3K	﹤0.01%	1316
2025 Q2	$381K	Sell	45,000 -75,000	-63%	-$601K	﹤0.01%	1179
2025 Q1	$965K	Buy	120,000 +70,000	+140%	+$567K	0.01%	930
2024 Q4	$449K	Sell	50,000 -40,000	-44%	-$326K	﹤0.01%	1131
2024 Q3	$660K	Buy	90,000 +30,000	+50%	+$186K	0.01%	878
2024 Q2	$343K	Buy	+60,000	New	+$316K	0.01%	878
2024 Q1	–	Sell	-289,100	Closed	-$2.6M	–	1196
2023 Q4	$2.6M	Buy	289,100 +171,600	+146%	+$1.41M	0.04%	540
2023 Q3	$913K	Buy	117,500 +67,500	+135%	+$660K	0.01%	789
2023 Q2	$484K	Sell	50,000 -100,000	-67%	-$1.04M	0.01%	825
2023 Q1	$1.64M	Buy	150,000 +85,000	+131%	+$749K	0.03%	503
2022 Q4	$281K	Sell	65,000 -25,000	-28%	-$145K	﹤0.01%	1014
2022 Q3	$676K	Buy	90,000 +10,000	+13%	+$86.6K	0.01%	994
2022 Q2	$804K	Hold	80,000	–	–	0.01%	950
2022 Q1	$990K	Sell	80,000 -129,100	-62%	-$2M	0.01%	979
2021 Q4	$4.78M	Buy	209,100 +122,500	+141%	+$2.9M	0.05%	471
2021 Q3	$1.92M	Sell	86,600 -73,400	-46%	-$1.16M	0.02%	775
2021 Q2	$2.07M	Buy	160,000 +40,000	+33%	+$510K	0.03%	664
2021 Q1	$1.56M	Sell	120,000 -377,200	-76%	-$5.47M	0.03%	577
2020 Q4	$6.88M	Buy	497,200 +34,300	+7%	+$499K	0.16%	179
2020 Q3	$6.82M	Buy	462,900 +196,000	+73%	+$2.84M	0.16%	155
2020 Q2	$4.34M	Sell	266,900 -11,000	-4%	-$176K	0.14%	192
2020 Q1	$4.03M	Sell	277,900 -271,700	-49%	-$4.79M	0.23%	128
2019 Q4	$11.1M	Buy	549,600 +199,000	+57%	+$1.83M	0.37%	54
2019 Q3	$1.87M	Buy	350,600 +150,600	+75%	+$911K	0.1%	256
2019 Q2	$1.32M	Buy	200,000 +50,000	+33%	+$319K	0.07%	321
2019 Q1	$974K	Buy	+150,000	New	+$995K	0.05%	359

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's AUPH Position: Q2 2026 in Review

Caption Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 216,363 shares worth $3.67M. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Caption Management previously reported a position in AUPH as recently as Q3 2025.

Caption Management first reported a position in AUPH in Q4 2019 and has held it in 19 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Caption Management held 216,363 shares of Aurinia Pharmaceuticals worth $3.67M as of Q2 2026.
Aurinia Pharmaceuticals was a new Caption Management position in Q2 2026.
Aurinia Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q2 2026, its #686 holding.
Caption Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and has held it in 19 quarters since.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.